Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

BioMarin and Suntory form strategic partnership for Phenoptin

Nov. 25, 2004

AstraZeneca reconfirms safety of Crestor

Nov. 23, 2004

Symbollon receives Canadian authorities' guidance for IoGen

Nov. 22, 2004

Emisphere signs agreement with Roche to develop oral formulations of compounds for bone diseases

Nov. 22, 2004

New orexin receptor antagonists claimed by Actelion

Nov. 22, 2004

Xagrid approved in E.U.

Nov. 22, 2004

Clinical assessment of ABX-10241 in secondary hyperparathyroidism begins

Nov. 22, 2004

Pioglitazone improves insulin resistance and carotid IMT in type 2 diabetes

Nov. 22, 2004

First market introductions of strontium ranelate for postmenopausal osteoporosis

Nov. 19, 2004

Approvable letter for Yaz

Nov. 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...